Aequus Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
The webpage is a zero-cost E,S&G report covering Aequus Pharmaceuticals Inc. The Disclosure score includes 17 UN SDGs including: 'Gender Equality', 'Sustainable Cities & Communities' and 'Partnerships for the Goals'. Jump to the bottom of the page for potential risks for Aequus Pharmaceuticals Inc based on industry, location and marketcap.
Aequus Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Aequus Pharmaceuticals Inc | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Aequus Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Aequus Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Aequus Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Aequus Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Aequus Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Aequus Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Aequus Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets Vistitan, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Tacrolimus IR, an immunosuppressant for the treatment and prevention of acute rejection following organ transplantation; Evolve dry eye products for various symptoms involved with dry eye disease and blepharitis, including discomfort, stinging, burning, and dryness; and preservative free ophthalmic product. Its development stage product includes Topiramate XR and Oxcarbazepine XR extended-release oral tablets for the treatment of epilepsy; AQS1303, a transdermal pyridoxine/doxylamine for the treatment of nausea and vomiting of pregnancy; and AQS1304, a cannabinoid based therapeutics for neurological disorders. The company has collaboration agreements with Sandoz Canada, Inc. for the promotion of Vistitan; Supernus Pharmaceuticals, Inc. for marketing of extended-release anti-epileptic drugs; and Medicom Healthcare Ltd. to focus on preservative free therapies in ophthalmology. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.